Dr. Antonio Finelli Bio
Chief of Urology, University Health Network GU Site Lead, Princess Margaret Cancer Center Associate Professor University of Toronto Phone (416) 946-2851 Assistant(s) Biography
Dr. Tony Finelli is a urologic oncologist and surgeon investigator at the University Health Network (UHN) in Toronto and an Associate Professor at the University of Toronto. He is the Chief of Urology, GU Site Lead at the Princess Margaret Cancer Center and the inaugural GU Oncology Lead for the province of Ontario (Cancer Care Ontario).
Dr. Finelli conducts health services research in urologic oncology with an interest in identifying gaps in care and designing knowledge translation strategies to overcome them. He is also actively involved in clinical trials. He has published more than 100 peer-reviewed manuscripts and holds peer-reviewed funding for research in prostate and kidney cancer.
Dr. Finelli’s clinical practice focuses on the management of urologic malignancies with minimally invasive and robotic techniques. He has performed live surgery for instructional purposes in more than 10 countries. Dr Finelli is recognized nationally and internationally for his contributions to minimally invasive urologic oncology. Areas of Specialty and Research Interests Affiliated Hospital(s) Princess Margaret Cancer Centre (UHN), Toronto General Hospital (UHN) Latest Publications Accuracy of renal tumour biopsy for the diagnosis and subtyping of papillary renal cell carcinoma: analysis of paired biopsy and nephrectomy specimens with focus on discordant cases. Related Articles
Accuracy of renal tumour biopsy for the diagnosis and subtyping of papillary renal cell carcinoma: analysis of paired biopsy and nephrectomy specimens with focus on discordant cases.
J Clin Pathol. 2019 Feb 12;:
Authors: Prendeville S, Richard PO, Jewett MAS, Kachura JR, Sweet JM, van der Kwast TH, Cheung CC, Finelli A, Evans AJ
Abstract AIMS: Renal tumour biopsy (RTB) is increasingly recognised as a useful diagnostic tool in the management of small renal masses, particularly those that are incidentally found. Intratumoural heterogeneity with respect to morphology, grade and molecular features represents a frequently identified limitation to the use of RTB. While previous studies have evaluated pathological correlation between RTB and nephrectomy, no studies to date have focused specifically on the role of RTB for the diagnosis of papillary renal cell carcinoma (PRCC) and its further subclassification into clinically relevant subtypes. METHODS: This single-institution study evaluated 60 cases of PRCC for concordance between RTB and nephrectomy with respect to diagnosis, grading and subtyping (type 1/type 2). RESULTS: We observed 93% concordance (55 of 59 evaluable cases) between RTB and nephrectomy for the diagnosis of PRCC, although seven tumours (12%) were undergraded on RTB. Subtyping of PRCC on RTB was concordant with nephrectomy in 89% of cases reported as type 1 PRCC on RTB (31/35), but only 40% of cases reported as type 2 PRCC on RTB (4/10). Morphological misclassification of PRCC on RTB was most likely to occur in tumours showing a solid growth pattern. Discordant PRCC subtyping most often occurred in tumours with eosinophilia/oncocytic change. CONCLUSION: There was good concordance between RTB and nephrectomy for the primary diagnosis of PRCC. Although further subtyping of PRCC can aid therapeutic stratification, this can be challenging on RTB and tumours with overlapping or ambiguous features are best reported as PRCC not otherwise specified pending development of more robust methods to facilitate definitive subclassification.
PMID: 30755496 [PubMed - as supplied by publisher]
( Dr. Antonio Finelli, Oncologist, Toronto, ON ) is in good standing with the College of Physicians and Surgeons.
If you are looking for local services or treatment in the office or hospital from a Oncologist, contact a provider such as ( Dr. Antonio Finelli ) with this phone number to inquire if they are accepting patients or you need a referral. Phone number to book an appointment (416) 946-2851The speaker in the video may have no association with ( Dr. Antonio Finelli, Oncologist, Toronto, ON ). ( Dr. Antonio Finelli, Oncologist ), may talk about some of the conditions and some of the treatment options shown in the videos on HealthChoicesFirst. Always talk with your health care practitioner about the information you learnt from the videos in regards to treatments and procedures the healthcare practitioner could perform and if they would be appropriate for you. Remember good information is the corner stone to understanding your condition or disease.Please contact ( Dr. Antonio Finelli, Oncologist, Toronto, ON ) to enquire if this health care provider is accepting new patients.
Ratings for Dr. Antonio Finelli, Oncologist, Toronto, ON
If you are the practitioner featured on this page and would like to either update the current information or claim the page please take advantage of our patient and physician resources here.
If on the other hand you would like to be removed for whatever reason from the directory please click here.
This content is for informational purposes only, and is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare professional with any questions you may have regarding a medical condition.